Merah Putih vaccine developed by an Indonesian biomedicine company, Biofarma, is still in progress.
And March 2020 will see the distribution of the vaccine to the industry and continue to a series of clinical tests.
In other words, there is still a long way to go.
The vaccine is reaching 60% of completion of its lab process, says Indonesian official.
But Indonesians are too tired and bored to wait for this sluggish progress.
In the end of 2020, we break boundaries and go wild.
It’s Christmas and New Year holiday anyway, and everyone feels entitled to enjoying some moments of unwinding after overworking and being tied at home like prisoners.